Tranexamic Acid Use and Blood Loss in Total Hip Arthroplasty | NCT02989155 | Trialant
CompletedObservationalLast updated Jan 20, 2017
Tranexamic Acid Use and Blood Loss in Total Hip Arthroplasty
Tranexamic Acid Use and Blood Loss in Total Hip Arthroplasty
Overview
ClinicalTrials.gov ID
NCT02989155
Lead Sponsor
Ohio State UniversityOTHER
Brief Summary
The purpose of this study is to determine the need for a blood transfusion during surgery and to evaluate the levels of certain proteins in the blood when given tranexamic acid.
Study Type
Observational
Phase
No data available
Enrollment
576Actual
Conditions
Tranexamic Acid UseBlood Loss
Interventions
No data available
Organization Study ID
2015H0427
Similar Studies
Status
Overall Status
Completed
Start Date
Jan 2016
Primary Completion Date
Dec 2016Actual
Completion Date
Dec 2016Actual
Study Record Dates
First Submitted
Dec 8, 2016
First Submitted that Met QC Criteria
Dec 8, 2016
First Posted
Dec 12, 2016Estimated
Last Update Submitted that Met QC Criteria
Jan 18, 2017
Last Update Posted
Jan 20, 2017Estimated
Last Verified
Jan 2017
NCT01683955Completed
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
NCT03825939Terminated
Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty
NCT00375440Withdrawn
Tranexamic Acid Study
NCT01866943Terminated
Role of Topical Tranexamic Acid in Total Hip Arthroplasty
NCT02584725Completed
Tranexamic Acid Dosing for Total Joint Arthroplasty